a public good project by the
Synthesis
Company
of California

© 2026

Maurizio Scarpa | doi.page

0 works0 citations0 h-index

Maurizio Scarpa

University of Udine(IT)

Publications by Year

Research Areas

Lysosomal Storage Disorders Research, Trypanosoma species research and implications, Glycogen Storage Diseases and Myoclonus, Cellular transport and secretion, Cystic Fibrosis Research Advances

Most-Cited Works

→ Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy(2007)516 cited
→ Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study(2006)363 cited
→ Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier(2012)303 cited
→ Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management(2011)296 cited
→ Possible strategies to cross the blood–brain barrier(2018)253 cited
→ ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo(1997)252 cited

→ A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency(2015)

241 cited

→ Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease(2011)230 cited

→ Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase(2008)216 cited

→ Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study(2014)210 cited